BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis
- PMID: 12893227
- DOI: 10.1016/s0090-8258(03)00365-2
BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis
Comment on
-
Pathologic findings in prophylactic oophorectomy specimens in high-risk women.Gynecol Oncol. 2002 Oct;87(1):52-6. doi: 10.1006/gyno.2002.6779. Gynecol Oncol. 2002. PMID: 12468342
Similar articles
-
The role of the fallopian tube in the origin of ovarian cancer.Am J Obstet Gynecol. 2013 Nov;209(5):409-14. doi: 10.1016/j.ajog.2013.04.019. Epub 2013 Apr 10. Am J Obstet Gynecol. 2013. PMID: 23583217 Free PMC article. Review.
-
Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.Histopathology. 2009 Mar;54(4):494-5. doi: 10.1111/j.1365-2559.2009.03237.x. Histopathology. 2009. PMID: 19309405 No abstract available.
-
Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.Histopathology. 2009 Nov;55(5):619. doi: 10.1111/j.1365-2559.2009.03408.x. Histopathology. 2009. PMID: 19912369 No abstract available.
-
The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.J Obstet Gynaecol Can. 2014 Feb;36(2):133-140. doi: 10.1016/S1701-2163(15)30659-9. J Obstet Gynaecol Can. 2014. PMID: 24518912 Review.
-
Women harboring BRCA1/2 germline mutations are at risk for breast and female adnexal carcinoma.Int J Gynecol Pathol. 2003 Jul;22(3):315-6; author reply 315-6. doi: 10.1097/01.PGP.0000079451.72325.63. Int J Gynecol Pathol. 2003. PMID: 12819403 No abstract available.
Cited by
-
Expression and T cell regulatory action of the PD-1 immune checkpoint in the ovary and fallopian tube.Am J Reprod Immunol. 2023 Mar;89(3):e13649. doi: 10.1111/aji.13649. Epub 2022 Dec 26. Am J Reprod Immunol. 2023. PMID: 36394352 Free PMC article.
-
Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.Neoplasia. 2011 Oct;13(10):899-911. doi: 10.1593/neo.11138. Neoplasia. 2011. PMID: 22028616 Free PMC article.
-
Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.Am J Surg Pathol. 2011 Nov;35(11):1605-14. doi: 10.1097/PAS.0b013e318229449f. Am J Surg Pathol. 2011. PMID: 21997682 Free PMC article.
-
Tumor evolution and chemoresistance in ovarian cancer.NPJ Precis Oncol. 2018 Sep 17;2:20. doi: 10.1038/s41698-018-0063-0. eCollection 2018. NPJ Precis Oncol. 2018. PMID: 30246154 Free PMC article. Review.
-
Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment.Front Oncol. 2013 Dec 4;3:295. doi: 10.3389/fonc.2013.00295. Front Oncol. 2013. PMID: 24363999 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous